Advances in Breast Cancer - Denver

January 22, 2022


The management of breast cancer is rapidly changing and increasingly complex due to advances in screening, detection, molecular testing, and treatment including surgery, radiation therapy, and pharmacologic therapies. Advances in Breast Cancer is designed to highlight the latest and most clinically impactful research from major medical conferences.

Expert faculty will review the latest podium research and discuss its application in practice with patient cases. Additionally, a faculty panel will provide perspectives on areas of clinical uncertainty or controversy in the management of breast cancer. This multidisciplinary conference is will assist oncologists, surgeons, radiation oncologists, nurse practitioners, physician assistants, pharmacists, and nurses in translating the latest information to practice in order to optimize care and outcomes for patients with breast cancer.


Early Bird Registration
Deadline January 3, 2022

General Registration

Physicians & Pharmacists



NPs, PAs, RNs, and others



Industry Employee**



Students & Fellows*

$0 (Free Registration)

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).

Intended Learners

This CME initiative is designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with breast cancer.

Planning Committee:

Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email/mailing address and payment information). This information is confidential and will only be used to contact you regarding your registration.
Cancellation Policy: Fees are non-refundable and non-transferable.


Saturday, January 22, 2022

Time Description
7:00am -7:50am

Registration Open & Breakfast Available in Exhibit Hall

7:50am - 8:00am

Welcome & Introductions

8:00am - 8:30am

(01) Latest on Genetic Testing in Breast Cancer

8:30am - 9:00am

(02) Radiation in Breast Cancer

9:00am - 9:30am

(03) Neoadjuvant Chemotherapy

9:30am - 10:00am

(04) Triple Negative Breast Cancer

10:00am - 10:20am

Break - Refreshments in Exhibit Hall

10:20am - 10:50am

(05) Update on Hormonal Therapy

10:50am - 11:20am

(06) Biology of Breast Cancer

11:20am - 12:05pm

(07) Update on Immunotherapy and IO Toxicity Management

12:05pm - 12:55pm

Lunch & Non-CE Symposium - Sponsored by: Pfizer

12:55pm - 1:15pm

Dessert Break

1:15pm - 1:45pm

(08) HER2+ Breast Cancer: Advances in Early Stage Disease

1:45pm - 2:15pm

(09) HER2+ Breast Cancer: Advances in Metastatic Disease

2:15pm - 2:45pm

(10) Stump the Faculty

CE Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME.

The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 5.25 contact hours and up to 3.25 pharmacology hours.

The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.

This conference is approved for up to 5.25 credit hours by the Washington State Pharmacy Association.

AMA PRA Category 1 Credit(s)

Accreditation Statement
Horizon CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Horizon CME designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:

  1. Login to the educational portal
  2. Participate in the educational activity
  3. Complete the online evaluation form
    The last day to access the evaluation is February 23, 2021 at 11:59pm (Pacific Time)*
  4. Attest to the number of hours in attendance in order to generate your certificate

*Requests from learners to claim credit after the evaluation closes will not be granted

Any questions? Please check out our FAQs section or feel free to contact us.

Excellent. We’ll need to sort out a few details.

* How did you hear about this activity?
Are you a Physician or Pharmacist (MD, DO, PharmD)?

*physician/pharmacist registration pricing is $50 for Early Bird, $65 for General

Are you a Pharmaceutical/Medical Device Industry Employee?

*Space is limited. The reduced registration fee is in place for oncology clinicians who are active in the field and involved in the management of care for their oncology patients. Industry Employees, including employees with a clinical degree (NP, PharmD, MD, PA-C, etc), can register for credit by clicking "YES" as an Industry Employee. 

IMPORTANT NOTICE TO PHARMACEUTICAL/MEDICAL DEVICE INDUSTRY EMPLOYEE WITH NON-CLINICAL DEGREES REGISTERING FOR APPOS (Not having a degree as an NP, PA, PharmD, RN, etc…) : In our efforts to ensure space for practicing clinicians, if you do not hold a clinical degree, your registration will be subject to the approval of our Medical Director and planning committee. As a CME conference, we need to ensure an appropriate balance of clinicians and Industry Personnel. Additionally, we also want to ensure that our Exhibitors have the maximum opportunity to interact with our attendees. Our Exhibitors paid a significant fee to support our conference and it would be unfair to them to have Industry Personnel circumventing the exhibit process.  
If your registration is not approved, you will receive a full refund. Thank you for your understanding and reverence to the conference Sponsors/Exhibitors.

ATTESTATION STATEMENT: I attest that as an attendee of the 2022 APP Oncology Summit in the role of Learner, I will not engage other attendees in detailing my company's products/services related to my role as a pharma/medical device industry employee.

None of the above